Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulator of MON1-CCZ1 complex (RMC1) is a highly conserved protein that functions as a scaffolding subunit within the MON1-CCZ1-RMC1 trimeric complex in metazoans, which is crucial for the activation of the small GTPase RAB7A and thus for endosomal maturation and autophagic flux[1][2]. RMC1 binds both MON1 and CCZ1, facilitating assembly of the complex and distinguishing the metazoan mechanism of endolysosomal trafficking from that in yeast and fungi, which lack this component[1][4]. The WD40 domain of RMC1 enables protein-protein interactions and likely provides a binding platform, while its unique MIC domain is important for complex assembly[4]. RMC1 localizes to endosomes and lysosomes and is important for lysosomal biology, protein trafficking, and possibly organismal development[1][4]. There is evidence implicating RMC1 in cancer, specifically colon cancer, although it is not established as a therapeutic target and no known drugs currently interact with this protein[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of MON1-CCZ1 complex (RMC1).